Optimizing Post-Acute Coronary Syndrome Dyslipidemia Management: Insights from the North American Acute Coronary Syndrome Reflective III.
Meshal AlaneziAndrew T YanMary K TanRonald BourgeoisPeiman Malek-MarzbanRani BeharrySuhaib AlkurtassGabor T GyenesPierre-Louis NadeauNduka NwadiaroSean JedrzkiewiczDongsheng GaoHarish ChandnaWilliam B NelsonShaun G Goodmannull nullPublished in: Cardiology (2024)
Although most patients post-ACS were on high-intensity statin therapy, almost 50% failed to achieve guideline-recommended LDL-C thresholds by 1-year follow-up. Furthermore, additional lipid-lowering therapies in this high-risk group were underprescribed, and this might be linked to several factors including potential gaps in physician knowledge, treatment inertia, patient refusal, and cost.
Keyphrases
- acute coronary syndrome
- high intensity
- percutaneous coronary intervention
- antiplatelet therapy
- end stage renal disease
- emergency department
- healthcare
- newly diagnosed
- chronic kidney disease
- primary care
- resistance training
- coronary artery disease
- peritoneal dialysis
- prognostic factors
- fatty acid
- type diabetes
- combination therapy
- mesenchymal stem cells
- human health
- patient reported